Current Gene Therapy
| Discipline | Gene therapy |
|---|---|
| Language | English |
| Edited by | Ignacio Anegon, MD |
| Publication details | |
| History | 2001-present |
| Publisher | |
| Frequency | Bimestrial |
| 5.318 (2012) | |
| Standard abbreviations | |
| ISO 4 | Curr. Gene Ther. |
| Indexing | |
| CODEN | CGTUAH |
| ISSN | 1566-5232 (print) 1875-5631 (web) |
| OCLC no. | 48623855 |
| Links | |
Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ignacio Anegon (INSERM UMR 1064, Nantes, France). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters").[1]
Abstracting and indexing
The journal is indexed in:[2][3]
According to the Journal Citation Reports, the journal has a 2012 impact factor of 5.318, ranking it 21st of 161 journals in the category "Genetics & Heredity".[4]
References
- ^ Publishers, Bentham Science. "BSP :: Current Gene Therapy". Archived from the original on 3 September 2011. Retrieved 4 August 2011.
{{cite web}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help) - ^ "List of indexing services". Current Gene Therapy. Bentham Science Publishers. August 2011. Archived from the original on 2011-09-03. Retrieved 2011-08-04.
{{cite web}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help) - ^ "Current Gene Therapy". CASSI. American Chemical Society. August 2011.
{{cite web}}:|access-date=requires|url=(help); Missing or empty|url=(help) - ^ "Journals Ranked by Impact: Genetics & Heredity". 2011 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2011.
{{cite book}}:|access-date=requires|url=(help)CS1 maint: postscript (link)